Advertisement
Research Article| Volume 43, ISSUE 8, P1269-1275, May 2007

Download started.

Ok

Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients

  • L. Sung
    Correspondence
    Corresponding author: Address: Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada. Tel.: +1 416 813 5287; fax: +1 416 813 5979.
    Affiliations
    Department of Paediatrics, University of Toronto, Toronto, Canada

    Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada

    Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada

    Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • G.A. Tomlinson
    Affiliations
    Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada

    Department of Medicine, University of Toronto, Toronto, Canada

    Department of Public Health Sciences, University of Toronto, Toronto, Canada
    Search for articles by this author
  • M.L. Greenberg
    Affiliations
    Department of Paediatrics, University of Toronto, Toronto, Canada

    Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • G. Koren
    Affiliations
    Department of Paediatrics, University of Toronto, Toronto, Canada

    Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada

    Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada

    Departments of Toxicology and Pharmacology, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • P. Judd
    Affiliations
    Department of Dentistry, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • S. Ota
    Affiliations
    Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author
  • B.M. Feldman
    Affiliations
    Department of Paediatrics, University of Toronto, Toronto, Canada

    Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada

    Department of Public Health Sciences, University of Toronto, Toronto, Canada

    Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada

    Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada
    Search for articles by this author

      Abstract

      The objectives were (1) to determine whether in children undergoing doxorubicin-containing chemotherapy, topical vitamin E decreases an objective measurement of oral mucositis compared to placebo, and (2) to assess the feasibility of an innovative trial design in paediatric cancer, combining N-of-1 trials using Bayesian meta-analysis. We conducted a series of N-of-1, double-blinded, randomised controlled trials in children ⩾ 6 years of age receiving repeated cycles of identical doxorubicin-containing chemotherapy. Each study cycle was followed by topical vitamin E (800 mg) or placebo.
      We enroled 16 children and 45 post chemotherapy cycles were randomised to vitamin E (N = 22) or placebo (N = 23). There was no difference in objective mucositis scores with a mean score of 0.2 with vitamin E and 0.3 with placebo. Topical vitamin E does not reduce doxorubicin-induced oral mucositis in children. The use of N-of-1 studies and Bayesian meta-analysis may facilitate the study of some therapies in paediatric oncology.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Karthaus M.
        • Rosenthal C.
        • Ganser A.
        Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies?.
        Bone Marrow Transplant. 1999; 24: 1095-1108
        • Sonis S.T.
        Oral complications of cancer therapy.
        in: De Vita Jr., V.T. Hellman S. Rosenberg S.A. Principles and practices of oncology. Lippincott-Raven, Philadelphia1993: 2385-2394
        • Clarkson J.E.
        • Worthington H.V.
        • Eden O.B.
        Interventions for preventing oral mucositis for patients with cancer receiving treatment.
        Cochrane Database Syst Rev. 2003; : CD000978
        • Myers C.E.
        • McGuire W.P.
        • Liss R.H.
        • Ifrim I.
        • Grotzinger K.
        • Young R.C.
        Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.
        Science. 1977; 197: 165-167
        • Kagan V.
        • Serbinova E.
        • Packer L.
        Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling.
        Biochem Biophys Res Commun. 1990; 169: 851-857
        • McGinness J.E.
        • Grossie Jr., B.
        • Proctor P.H.
        • Benjamin R.S.
        • Gulati O.P.
        • Hokanson J.A.
        Effect of dose schedule of vitamin E and hydroxethylruticide on intestinal toxicity induced by adriamycin.
        Physiol Chem Phys Med NMR. 1986; 18: 17-24
        • Lopez I.
        • Goudou C.
        • Ribrag V.
        • Sauvage C.
        • Hazebroucq G.
        • Dreyfus F.
        Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents.
        Ann Med Interne (Paris). 1994; 145: 405-408
        • Wadleigh R.G.
        • Redman R.S.
        • Graham M.L.
        • Krasnow S.H.
        • Anderson A.
        • Cohen M.H.
        Vitamin E in the treatment of chemotherapy-induced mucositis.
        Am J Med. 1992; 92: 481-484
        • Zucker D.R.
        • Schmid C.H.
        • McIntosh M.W.
        • D’Agostino R.B.
        • Selker H.P.
        • Lau J.
        Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
        J Clin Epidemiol. 1997; 50: 401-410
        • Spiegelhalter D.J.
        • Myles J.P.
        • Jones D.R.
        • Abrams K.R.
        Bayesian methods in health technology assessment: a review.
        Health Technol Assess. 2000; 4: 1-130
        • Johnson G.
        • Nelson S.
        • Petric M.
        • Tellier R.
        Comprehensive PCR-based assay for detection and species identification of human herpesviruses.
        J Clin Microbiol. 2000; 38: 3274-3279
        • Sonis S.T.
        • Eilers J.P.
        • Epstein J.B.
        • LeVeque F.G.
        • Liggett Jr., W.H.
        • Mulagha M.T.
        • et al.
        Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.
        Cancer. 1999; 85: 2103-2113
      1. World Health Organization. Handbook for reporting results of cancer treatment. Geneva; 1979.

        • McCullagh P.
        • Nelder J.A.
        Generalized linear models.
        2nd ed. Chapman and Hall, New York1989
        • Sung L.
        • Hayden J.
        • Greenberg M.L.
        • Koren G.
        • Feldman B.M.
        • Tomlinson G.A.
        Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study.
        J Clin Epidemiol. 2005; 58: 261-268